D. Sargent, H. Wieand, D. Haller, R. Gray, J. Benedetti et al., Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials, Journal of Clinical Oncology, vol.23, issue.34, pp.8664-70, 2005.
DOI : 10.1200/JCO.2005.01.6071

K. Oba, X. Paoletti, S. Alberts, Y. Bang, J. Benedetti et al., Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis, JNCI Journal of the National Cancer Institute, vol.105, issue.21
DOI : 10.1093/jnci/djt270

S. Halabi, B. Rini, B. Escudier, W. Stadler, and E. Small, Progression-free survival as a

X. Paoletti, K. Oba, Y. Bang, H. Bleiberg, N. Boku et al., Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis, JNCI Journal of the National Cancer Institute, vol.105, issue.21, pp.1667-70, 2013.
DOI : 10.1093/jnci/djt269

R. Adam, P. Bhangui, G. Poston, D. Mirza, G. Nuzzo et al., Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Annals of surgery, pp.774-87, 2010.